To further elucidate whether targeting SDCBP enhances the anti-cancer activity of metformin in a TNBC model, murine 4T1 cells were infected with adenoviral SDCBP shRNA, resulting in the complete loss of SDCBP and BACH1 expression (Fig. EV1J). This evidence concerns the gene BACH1 and cancer.